SC Johnson
SC Johnson develops low-cost spatial repellent products that release repellent into rooms or semi-enclosed spaces, building on more than 60 years of insect-science expertise at its Center for Insect Science and Family Health. Its U.S. R&D is based in Racine, Wisconsin, where development of Guardian™ was led; Guardian™ is manufactured in Nairobi, Kenya, and Buenos Aires, Argentina. Its malaria work spans the development and delivery stages: Guardian™ is WHO-prequalified, has regulatory approval in 29 countries, has been deployed in 24 countries, and is being supplied under a May 2026 State Department–Global Fund agreement, while further field evaluation of its spatial repellents continues. SC Johnson also operates 86 community health clinics across five countries, serving more than 3 million people annually, and its global public health solutions have reached more than 115 million people.
What they do
SC Johnson develops low-cost spatial repellent products that release repellent into rooms or semi-enclosed spaces, building on more than 60 years of insect-science expertise at its Center for Insect Science and Family Health. Its U.S. R&D is based in Racine, Wisconsin, where development of Guardian™ was led; Guardian™ is manufactured in Nairobi, Kenya, and Buenos Aires, Argentina. Its malaria work spans the development and delivery stages: Guardian™ is WHO-prequalified, has regulatory approval in 29 countries, has been deployed in 24 countries, and is being supplied under a May 2026 State Department–Global Fund agreement, while further field evaluation of its spatial repellents continues. SC Johnson also operates 86 community health clinics across five countries, serving more than 3 million people annually, and its global public health solutions have reached more than 115 million people.
- Racine, WIHeadquarters · Research and development
In the field and in development
86 clinics in Kenya, Rwanda, Tanzania, Indonesia, and South Sudan
Partnerships in 2 endemic countries
- Government of Kenya · April 2023 public-private partnership (more than $10 million) to distribute spatial repellents, fund malaria-prevention education, and build rural clinics
- Ifakara Health Institute · field testing of Guardian™ against pyrethroid-resistant Anopheles arabiensis mosquitoes (2022–2023)
- Multiple countries (humanitarian settings in 7 countries) — The MENTOR Initiative (UK-headquartered, with in-country presence in 10+ countries) — partner since 2012 providing insect-borne disease prevention in humanitarian settings
- ~30 malaria-endemic countries — additional partnerships not individually listed; Guardian™ deployed in 24 countries to date.
Who they work with in the United States
- U.S. Department of State
Where this comes from
This profile was confirmed by the organization.